Guerbet Aktie
25,90EUR | -0,15EUR | -0,58% |
WKN: 870481 / ISIN: FR0000032526
Aktionärsstruktur
Inhaber | in % |
---|---|
Guerbet Family | 53,25 |
Freefloat | 42,59 |
Guerbet SA Employees Stock Ownership Plan | 3,66 |
HealthInvest Small & Micro Cap Fund | 3,24 |
Echiquier SICAV - Value Euro | 2,18 |
Government Pension Fund - Global (The) | 1,50 |
Amundi Actions PME | 1,45 |
Quaero Capital Funds LUX SICAV - Argonaut | 1,43 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 2 820 | 2 635 | 2 730 | 2 839 | 2 920 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,29 | 0,27 | 0,27 | 0,27 | 0,27 |
Bilanz (in Mio. EUR) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 515 | 469 | 495 | 510 | 582 |
Summe Anlagevermögen | 494 | 477 | 505 | 430 | 444 |
Summe Aktiva | 1 009 | 946 | 1 001 | 940 | 1 025 |
Bilanz (in Mio. EUR) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 378 | 353 | 334 | 312 | 384 |
Summe Fremdkapital | 620 | 581 | 596 | 560 | 647 |
Summe Eigenkapital | 389 | 364 | 405 | 380 | 378 |
Summe Passiva | 1 009 | 946 | 1 001 | 940 | 1 025 |
Adresse
15, rue des Vanesses, 93420 Paris | |
Telefon | +33 (1) 45-91-50-00 |
Internet | http://www.guerbet.com |
Management
Carine Dagommer
Director |
Charlotte Bamière
Senior Vice President-Compliance & General Counsel |
Claire Massiot-Jouault
Non-Independent Director |
Céline Lamort
Non-Independent Director |
Dan Raffi
Director-Commercial Operations |
David Hale
Chief Executive Officer |
Didier Izabel
Independent Director |
Eric Guerbet
Director |
Eva Ohlsson
Senior Vice President-Human Resources |
François Nicolas
Chief Digital Officer, Senior Vice President-R&D |
Jean-Hugues Louis Lecat
Chairman |
Jean-Sébastien Raynaud
Director |
Jérôme Estampes
CFO, Senior VP-Business Development & Licensing |
Marc Massiot
Director |
Marie de la Simone
Director |
Mark Fouquet
Non-Independent Director |
Nicolas Louvet
Non-Independent Director |
Pascale Auger
Independent Director |
Philippe Bourrinet
SVP-Development, Medical & Regulatory Affairs |
Raoul Bernhardt
Director-Industrial Operations |
Valérie Brissart
Senior Vice President Marketing-Diagnostic Imaging |